As of Sep 28
| -0.0127 / -11.55%|
The 1 analysts offering 12-month price forecasts for Immune Therapeutics Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +20,454.98% increase from the last price of 0.10.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.